Search Results 171-180 of 18123 for CLL
-
... CLL to patients with untreated intermediate and high-risk CLL. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...
-
... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...
-
... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.
-
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy ...
-
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy ...
-
... Chronic lymphocytic leukemia/ Small lymphocytic lymphoma (CLL/SLL) with * At least 2 lines of prior therapy (Part 1 only) * Part 2 Cohort A: CLL/SLL ...
-
... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.
-
... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...
-
... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.
-
Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experience. Blood Cancer J ...